Volume 12, Number 10—October 2006
Research
Human Prion Disease and Relative Risk Associated with Chronic Wasting Disease
Table A1
Code definition | Age at death, y | ICD-9 | Total with code* (12–55 y)† |
---|---|---|---|
Slow virus infection of the central nervous system | >12 | 046 | 0 (0) |
Creutzfeldt-Jakob disease | >12 | 046.1 | 54 (8) |
Other slow virus infection | >12 | 046.8 | 0 (0) |
Unspecified slow virus infection | >12 | 046.9 | 0 (0) |
Presenile dementia | 12–55 | 290.1 | 8 (8) |
Senile dementia, depressed or paranoid type | 12–55 | 290.2 | 0 (0) |
Cognitive or personality change of other type | >12 | 310.1 | 0 (0) |
Other cerebral degenerations | >12 | 331 | 0 (0) |
Alzheimer disease | 12–55 | 331.0 | 18 (18) |
Pick disease | >12 | 331.1 | 19 (3) |
Senile degeneration of the brain | >12 | 331.2 | 55 (0) |
Other cerebral degeneration | >12 | 331.8 | 13 (8) |
Other cerebral degeneration, unspecified | >12 | 331.9 | 569 (35) |
Other extrapyramidal disease and abnormal movement disorders | >12 | 333 | 0 (0) |
Other degenerative diseases of the basal ganglia | >12 | 333.0 | 78 (8) |
Myoclonus | >12 | 333.2 | 4 (1) |
Other choreas | >12 | 333.5 | 11 (0) |
Other and unspecified conditions | >12 | 333.9 | 22 (1) |
Spinocerebellar disease | >12 | 334 | 0 (0) |
Primary cerebellar degeneration | >12 | 334.2 | 7 (0) |
Other cerebellar ataxia | >12 | 334.3 | 18 (1) |
Cerebellar ataxia in diseases classified elsewhere | >12 | 334.4 | 0 (0) |
Other spinocerebellar disease | >12 | 334.8 | 27 (6) |
Unspecified spinocerebellar disease | >12 | 334.9 | 66 (6) |
Encephalopathy, unspecified | >12 | 348.3 | 620 (183) |
Sleep disturbances | >12 | 780.5 | 7 (1) |
Abnormal involuntary movements | >12 | 781.0 | 22 (2) |
Abnormality of gait | >12 | 781.2 | 13 (1) |
Lack of coordination | >12 | 781.3 | 49 (0) |
*Deaths may have more than 1 code reported.
†Total deaths with code for persons ages 12–55 y.
Page created: December 05, 2011
Page updated: December 05, 2011
Page reviewed: December 05, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.